Angiotensin II type I receptor antagonism prevents nicotine-induced cardiac dysfunction in rats

被引：0
|
作者：
Ramalingam, Anand [1 ]
Fauzi, Norsyahida Mohd. [1 ]
Budin, Siti Balkis [1 ]
Ritchie, Rebecca [2 ]
Zainalabidin, Satirah [1 ]
机构：
[1] Univ Kebangsaan Malaysia, Kuala Lumpur, Malaysia
[2] Baker Heart & Diabet Inst, Melbourne, Vic, Australia
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2020年 / 140卷
关键词：
D O I：
10.1016/j.yjmcc.2019.11.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Tue-061
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
    Ramalingam, Anand
    Budin, Siti Balkis
    Fauzi, Norsyahida Mohd
    Ritchie, Rebecca H.
    Zainalabidin, Satirah
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [2] Roselle supplementation prevents nicotine-induced vascular endothelial dysfunction and remodelling in rats
    Si, Lislivia Yiang-Nee
    Kamisah, Yusof
    Ramalingam, Anand
    Lim, Yi Cheng
    Budin, Siti Balkis
    Zainalabidin, Satirah
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2017, 42 (07) : 765 - 772
  • [3] BRADYKININ B1 RECEPTOR ANTAGONISM PREVENTS ANGIOTENSIN II-INDUCED ERECTILE DYSFUNCTION
    McCormick, B. A.
    Hannan, J. L.
    Huot-Marchand, J. E.
    Carroll, C.
    Carrier, S.
    deBlois, D.
    Hale, T. M.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E29 - E29
  • [4] Angiotensin II receptor antagonism and insulin action in type I muscle of obese Zucker rats.
    Kinnick, TR
    Jacob, S
    Krekler, M
    Henriksen, EJ
    DIABETOLOGIA, 2000, 43 : A169 - A169
  • [5] Angiotensin II receptor subtype I antagonism and diastolic cardiac filling in man
    Shiels, P
    Lim, PO
    Leary, AC
    McMahon, AD
    MacDonald, TM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (03) : 337 - 338
  • [6] C-type natriuretic peptide prevents angiotensin II-induced cardiac remodelling and dysfunction
    Konstanze Roloff
    Franziska Werner
    Marco Abeßer
    Katharina Völker
    Hideo A Baba
    Kai Schuh
    Michaela Kuhn
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [7] Angiotensin II receptor antagonism ameliorates endothelial dysfunction and reduces inflammation in hypertensive rats
    Sanz-Rosa, D
    Cediel, E
    de las Heras, N
    Miana, M
    Lahera, V
    Cachofeiro, V
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 17 - 17
  • [8] Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats
    De Smet, HR
    Menadue, MF
    Oliver, JR
    Phillips, PA
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (04) : 278 - 283
  • [9] Cardiomyocyte-specific deletion of type I TGF-β receptor prevents angiotensin II-induced p38 activation, cardiac hypertrophy, and dysfunction
    Pokharel, S
    Sharma, UC
    Janssen, S
    van Leeuwen, RE
    Pinto, YM
    CIRCULATION, 2004, 110 (17) : 225 - 225
  • [10] Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats
    Minas, Jacqueline N.
    Thorwald, Max A.
    Conte, Debra
    Vazquez-Medina, Jose-Pablo
    Nishiyama, Akira
    Ortiz, Rudy M.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (11): : 1178 - 1188
12345